Cargando…
Sodium valproate in pregnancy: what are the risks and should we use a shared decision-making approach?
BACKGROUND: Despite significant teratogenic risks, sodium valproate is still widely prescribed in many countries to women of childbearing age, as a mood stabiliser in bipolar disorder and also in epilepsy. The UK has recently banned valproate use in women who are not in a pregnancy prevention progra...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984824/ https://www.ncbi.nlm.nih.gov/pubmed/29859057 http://dx.doi.org/10.1186/s12884-018-1842-x |